Our history
We are a world leader in Specialized Diagnostics and throughout our history we have achieved milestone after milestone, always with the aim of advancing patient care. Explore our history to discover the strategic moves and innovations that make us the company we are today.
- Corporate Milestones
- Product Innovations
-
2023
Acquisition of Immucor
Creation and integration of two new business lines: Transfusion and Transplant. Integration underway and according to plan
-
2021
One Company, One Team
Werfen restructures and unites under one brand
-
2020
Aptiva®
Aptiva is a fully automated multi-analyte system that represents the next generation of high throughput instruments for the clinical laboratory
-
2020
COVID-19 pandemic
Werfen organizes to face challenges brought on by the pandemic
-
2019
Handover of leadership
Marc Rubiralta appointed Chairman
-
2019
GEM Premier® ChemSTAT
First multi-use cartridge analyzer with rapid, lab-quality BMP, including Crea, Hct, Lac, pH, and pCO2, in the ED
-
2017
GEM® Premier™ 5000
New generation, multi-use cartridge analyzer with iQM®2
-
2017
Acquisition of Accriva Diagnostics
Global leader in Whole Blood Hemostasis testing at the point-of-care
(USA)
-
2016
New Logistics Center for Iberia
Located in Tarancón,
Cuenca, Spain
Acquisition of TEM®
Expertise in viscoelastic technology and Patient Blood Management at
the point-of-care
-
2015
ACL TOP® Family 50 Series
Next-generation ACL TOP Family with pre-analytical sample checks
-
2013
BIO-FLASH®
Full commercial launch of BIO-FLASH, for use by clinical reference and hospital laboratories. Tests previously requiring significant hands-on time automated on this intuitive and rapid system.
-
2012
The Next Generation
Jordi Rubiralta appointed Chairman
-
2011
Inauguration of Torre Werfen
New headquarters in Barcelona, Spain
-
2009
Acquisition of the Autoimmune Diagnostics business of The Binding Site
Strengthening leadership in Autoimmunity Diagnostics
(UK)
-
2009
ACL AcuStar® System
First and only fully automated, high-sensitivity system with chemiluminescence for Hemostasis testing
-
2008
Acquisition of Inova Diagnostics
Leader in Autoimmunity Diagnostics
(San Diego, USA)
-
2006
GEM® Premier™ 4000
First blood gas analyzer with multi-use cartridge and integrated CO-oximetry
-
2004
ACL TOP Family Series
First fully automated and standardized system for Hemostasis testing
-
2000
GEM Premier 3000
First standardized blood gas testing platform with multi-use cartridge
-
1999
Acquisition of Hemoliance
Strengthening leadership in Hemostasis Diagnostics
(USA)
-
1996
Acquisition of Chromogenix (Sweden) and Mallinckrodt Sensor Systems (USA)
Progressive expansion in the Hemostasis and Blood Gas markets
-
1991
Acquisition of Instrumentation Laboratory
Global leader in Hemostasis and Blood Gas systems
(Bedford, MA, USA)
-
1985
ACL 810 System
First fully automated mid-sized Hemostasis analyzer
-
1981
IL1303
First blood gas analyzer with video display and continuous calibration
-
1979
Geographical expansion
Launch in Latin America
Founding of Leventon (Barcelona, Spain)
Infusion Therapy manufacturing begins
-
1974
Founding of Instrumentación Científica
Scientific instrumentation distributor in Iberia; now Izasa Scientific
(Barcelona, Spain)
-
1973
Founding of Biokit
First steps into manufacturing
(Barcelona, Spain)
-
1967
IL182
Invention of CO-oximetry, the technique that measures total hemoglobin and oxygenation parameters
-
1966
José María Rubiralta founds Izasa with the support of his family
Now Werfen
(Barcelona, Spain)
-
1964
IL143
First Flame Photometer. Revolutionized chemistry electrolyte testing in the laboratory
-
1963
IL113
First blood gas analyzer for routine clinical testing
-
1959
IL105
First direct reading pH/blood gas analyzer